About
Anivive Lifesciences is an innovative veterinary biotechnology company that combines cutting-edge AI with deep scientific expertise to transform the standard of care for companion animals. Their end-to-end platform spans specialty diagnostics, precision oncology, drug discovery, and clinical trial access — all powered by intelligent technology. At the core of their offering is SearchLight DNA, a next-generation tumor genotyping service that analyzes cancer DNA to empower veterinarians with personalized treatment plans tailored to each pet's unique disease profile. An AI imaging module, trained on thousands of X-rays, uses deep convolutional neural networks to detect systemic fungal infections like Valley Fever in dogs with high diagnostic accuracy. Anivive's intelligent research engine — powered by over 1 billion data points and decades of global veterinary research — continuously gathers, analyzes, and develops new insights to identify the most promising drug candidates for pets. This data-driven approach accelerates development timelines and helps keep treatments more affordable. The company also operates a centralized clinical trial marketplace that matches pets to studies based on their individual medical profiles, expanding access to life-saving therapies by 10x while speeding the enrollment process by up to 80%. Specialty pathology services, led by top veterinary oncology experts, round out the platform. Anivive is actively building a pipeline of treatments and vaccines targeting canine Valley Fever, Feline Infectious Peritonitis (FIP), Blastomycosis, Hemangiosarcoma, and more. The platform is designed for veterinary professionals, clinical researchers, and pet owners seeking advanced, technology-driven care.
Key Features
- SearchLight DNA Tumor Genotyping: Next-generation genomic sequencing that profiles tumor DNA to help veterinarians build personalized cancer treatment plans for pets.
- AI Imaging for Fungal Diagnosis: A deep learning module trained on thousands of X-rays that detects systemic fungal infections like Valley Fever in dogs using convolutional neural networks.
- AI-Powered Drug Discovery Engine: An intelligent research platform with 1 billion+ data points that identifies promising veterinary therapeutics and predicts efficacy to accelerate drug development.
- Clinical Trial Marketplace: A centralized marketplace that matches pets to relevant clinical studies based on their medical profile, accelerating enrollment by up to 80% and expanding access 10x.
- Specialty Veterinary Pathology Services: Expert-led oncology pathology services powered by innovative technology, ensuring the highest diagnostic standard of care for animal patients.
Use Cases
- Veterinary oncologists using SearchLight DNA to identify targeted cancer therapies personalized to a pet's tumor genetic profile
- Radiologists and diagnosticians leveraging AI imaging to detect Valley Fever and other systemic fungal infections from dog X-rays
- Pharmaceutical researchers using the AI drug discovery engine to prioritize and fast-track the most promising veterinary drug candidates
- Pet owners enrolling their animals in clinical trials through the marketplace to gain access to experimental life-saving treatments
- Veterinary pathology labs integrating Anivive's specialty oncology services for expert-driven, technology-powered diagnostic accuracy
Pros
- End-to-End AI Platform: Covers diagnostics, drug discovery, and clinical trial access in a single integrated ecosystem, providing comprehensive support for advanced veterinary care.
- Precision Medicine for Pets: SearchLight DNA enables personalized, targeted cancer treatments rather than one-size-fits-all approaches, meaningfully improving patient outcomes.
- Expanded Clinical Trial Access: The trial marketplace helps 10x more pets connect with potentially life-saving experimental therapies, addressing a major gap in veterinary care access.
- Data-Driven Research at Scale: With over 1 billion data points and decades of global research ingested, the AI engine provides robust, evidence-based insights for drug development.
Cons
- Exclusively Veterinary-Focused: The platform is designed solely for pet health, making it inapplicable to human medicine or non-veterinary research contexts.
- Cost of Advanced Diagnostics: Specialty services like tumor genotyping and expert pathology may carry significant costs, potentially limiting accessibility for some pet owners.
- Narrow Disease Pipeline: Current drug development targets a specific set of conditions, leaving many other pet health needs unaddressed in the near term.
Frequently Asked Questions
What is SearchLight DNA?
SearchLight DNA is Anivive's next-generation tumor genotyping service that analyzes the genetic profile of a pet's cancer to help veterinarians design personalized, targeted treatment plans.
What is Valley Fever and how is Anivive addressing it?
Valley Fever (Coccidioidomycosis) is a fungal infection that currently has no vaccine and is spreading. Anivive is developing a novel canine vaccine and an AI imaging module that uses deep learning to detect the disease from X-rays.
How does the clinical trial marketplace work?
Anivive's marketplace matches pets to open clinical studies based on their individual medical profiles. The platform manages recruitment and accelerates the inclusion/exclusion enrollment phase by 80%, connecting far more animals to experimental treatments.
What conditions is Anivive currently developing treatments for?
Anivive's active pipeline includes a canine Valley Fever vaccine, a Feline FIP treatment, a canine Blastomycosis vaccine, a canine Hemangiosarcoma therapeutic, and a canine/feline Gingivitis treatment.
Who is Anivive's platform designed for?
Anivive serves veterinary professionals seeking advanced diagnostics and pathology, clinical researchers running pet studies, pharmaceutical developers using the AI discovery engine, and pet owners looking to enroll their animals in clinical trials.
